InvestorsHub Logo
Followers 18
Posts 1229
Boards Moderated 0
Alias Born 02/14/2007

Re: biopharm post# 288452

Thursday, 03/02/2017 9:34:05 PM

Thursday, March 02, 2017 9:34:05 PM

Post# of 346060
So Ronin is in Xencor, who partnered with Novartis. Novartis has I/O in PD-1, Lag3, T-cells, and others.

https://www.novartis.com/news/media-releases/novartis-continues-grow-immuno-oncology-pipeline-through-collaboration-and

PPHM has several abstracts at AACR involving PD-1, Lag3, and T-cells.

Ronin pops up with a big buy in PPHM.

Hmmmm . . .

IMO

PD
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News